Detalles de la búsqueda
1.
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage.
Histopathology
; 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38828674
2.
Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer.
JAMA
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38814624
3.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
; 36(10): 100241, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37343766
4.
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance Study.
Nutr Cancer
; 75(2): 618-626, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36343223
5.
Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer.
Cancer
; 128(2): 269-274, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516660
6.
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
Mod Pathol
; 35(8): 1092-1100, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35145197
7.
Evaluating the Outcomes of Active Surveillance in Grade Group 2 Prostate Cancer: Prospective Results from the Canary PASS Cohort.
J Urol
; 207(4): 805-813, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34854745
8.
Impact of Prostate Health Index Results for Prediction of Biopsy Grade Reclassification During Active Surveillance.
J Urol
; 208(5): 1037-1045, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830553
9.
Prostate cancer mortality and metastasis under different biopsy frequencies in North American active surveillance cohorts.
Cancer
; 126(3): 583-592, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31639200
10.
Magnetic Resonance Imaging for the Detection of High Grade Cancer in the Canary Prostate Active Surveillance Study.
J Urol
; 204(4): 701-706, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32343189
11.
African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
J Urol
; 203(4): 727-733, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651227
12.
Continued 5α-Reductase Inhibitor Use after Prostate Cancer Diagnosis and the Risk of Reclassification and Adverse Pathological Outcomes in the PASS.
J Urol
; 201(1): 106-111, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30076904
13.
Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.
Ann Intern Med
; 168(1): 1-9, 2018 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29181514
14.
Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.
J Urol
; 197(4): 1026-1033, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27810448
15.
Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.
Prostate
; 76(15): 1409-19, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27325561
16.
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.
J Urol
; 195(2): 313-20, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26327354
17.
18.
Exploring the relation of active surveillance schedules and prostate cancer mortality.
Cancer Med
; 13(5): e6977, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38491826
19.
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker.
Sci Rep
; 14(1): 486, 2024 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38177207
20.
A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.
Adv Anat Pathol
; 20(1): 39-44, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23232570